Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic aberrations relate early and advanced stage ovarian cancer.
Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, Ylstra B, Zweemer RP; EORTC GCG Translational Research Group. Zaal A, et al. Among authors: vergote i. Cell Oncol (Dordr). 2012 Jun;35(3):181-8. doi: 10.1007/s13402-012-0077-5. Epub 2012 May 12. Cell Oncol (Dordr). 2012. PMID: 22581446 Free PMC article.
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, Vermorken JB, Torri V, Mangioni C, Pecorelli S, Lissoni A, Swart AM; International Collaborative Ovarian Neoplasm 1; European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm. Trimbos JB, et al. Among authors: vergote i. J Natl Cancer Inst. 2003 Jan 15;95(2):105-12. J Natl Cancer Inst. 2003. PMID: 12529343 Clinical Trial.
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S; EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Trimbos JB, et al. Among authors: vergote i. J Natl Cancer Inst. 2003 Jan 15;95(2):113-25. J Natl Cancer Inst. 2003. PMID: 12529344 Clinical Trial.
The role of interval debulking surgery in ovarian cancer.
van der Burg ME, Vergote I; Gynecological Cancer Group of the EORTC. van der Burg ME, et al. Among authors: vergote i. Curr Oncol Rep. 2003 Nov;5(6):473-81. doi: 10.1007/s11912-003-0008-8. Curr Oncol Rep. 2003. PMID: 14521806 Review.
The management of borderline tumours of the ovary.
Cadron I, Amant F, Van Gorp T, Neven P, Leunen K, Vergote I. Cadron I, et al. Among authors: vergote i. Curr Opin Oncol. 2006 Sep;18(5):488-93. doi: 10.1097/01.cco.0000239889.98289.ce. Curr Opin Oncol. 2006. PMID: 16894298 Review.
Ovarian cancer.
Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I. Colombo N, et al. Among authors: vergote i. Crit Rev Oncol Hematol. 2006 Nov;60(2):159-79. doi: 10.1016/j.critrevonc.2006.03.004. Epub 2006 Oct 2. Crit Rev Oncol Hematol. 2006. PMID: 17018256 Review.
A new prognostic model for FIGO stage 1 epithelial ovarian cancer.
Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N. Obermair A, et al. Among authors: vergote i. Gynecol Oncol. 2007 Mar;104(3):607-11. doi: 10.1016/j.ygyno.2006.09.021. Epub 2006 Nov 7. Gynecol Oncol. 2007. PMID: 17092548
888 results